ロード中...
Severe thrombocytopenia after trastuzumab retreatment: a case report
BACKGROUND: Trastuzumab prolongs survival of human epidermal growth factor receptor 2-positive breast cancer patients in both the adjuvant and metastatic settings. Currently toxicity data are not available on retreatment of metastatic breast cancer patients who relapse after adjuvant trastuzumab. We...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3851485/ https://ncbi.nlm.nih.gov/pubmed/24093447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-6-400 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|